# Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML

> **NCT02427919** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Seoul St. Mary's Hospital** · enrollment: 56 (estimated)

## Conditions studied

- Leukemia, Myeloid, Acute

## Interventions

- **DRUG:** G-CSF

## Key facts

- **NCT ID:** NCT02427919
- **Lead sponsor:** Seoul St. Mary's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2015-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02427919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02427919, "Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02427919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*